CHE
NYSECHEMED CORPORATION
Healthcare · Services-Home Health Care Services
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$1.3B
2021
$1.2B
2022
$1.3B
2023
$1.6B
2024
$2.5B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$2.5B
Net Income$265,238
Gross Profit—
Oper Income$338.2M
EPS (dil)$18.34
Rev/sh$190.60
FCF/sh$24.52
Book/sh$73.78
Gross M—
Oper M13.4%
Profit M0.0%
FCF M12.9%
ROE0.0%
ROA0.0%
ROIC27.1%
R&D/Rev—
Rev Y/Y61.5%
Rev 3Y CAGR27.1%
EPS Y/Y-7.8%
EPS 3Y CAGR3.5%
FCF 3Y CAGR8.8%
Payout11950%
Div/sh—
Shs Chg Y/Y-4.8%
Current Ratio1.05
Quick Ratio1.03
Debt/Eq0.03
Int Coverage193.3×
Net Debt$48.3M cash
Total Debt$26.3M
Cash & Eq$74.5M
Total Assets$1.5B
Oper CF$388.3M
Capex$62.8M
Free CF$325.5M
Buybacks$431.5M
Equity$979.4M
Liabilities$558.8M
Shs Outstand0.01B
SectorHealthcare
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.3B | $1.6B | $2.5B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $343.0M | $343.5M | $340.6M | $366.5M | $338.2M |
| Net Income | $268,550 | $249,624 | $272,509 | $301,999 | $265,238 |
| Diluted EPS | $16.85 | $16.53 | $17.93 | $19.89 | $18.34 |
| Operating Cash Flow | $308.6M | $309.9M | $330.3M | $417.5M | $388.3M |
| Free Cash Flow | $249.9M | $252.6M | $273.4M | $368.0M | $325.5M |
COMMUNITY · $CHE0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.